Process developments Sample Clauses

Process developments. 6.1 The Parties acknowledge that the Background IP of Purchaser or Supplier is and will remain the separate property of Purchaser or Supplier, as the case may be and are not affected by this Agreement. Except as expressly permitted under this Agreement, neither Party shall have any claims to or rights in or to such separate Background IP of the other Party.
Sample 1
AutoNDA by SimpleDocs
Process developments. Printing processes for a wide range of materials were developed. The level of maturity varies. For some materials printability was evaluated, for others further developments were made. Printability was confirmed for semiconductors synthesized at UPD as well as for the commercially available P3CPT. A special technique for patterning P3HT was developed, in which an SU8 well is printed around the channel area. When P3HT is printed inside the well, SU8 attracts it, resulting in a thin and smooth P3HT layer in the middle of the well, where the channel is. This is important because thick and non-uniform layers are believed to decrease performance and stability. Ag, Au and PEDOT electrodes were printed by inkjet. All electrode materials were also overprinted with P3HT and transistor characterizations made using DI water as electrolyte. A modulation was observed in all structures but processes were only optimized further for Au/P3HT. Characterization data for an EGOFET with printed Au electrodes (UTDAu25TE) and printed P3HT is shown in Figure
Sample 1

Related to Process developments

  • Business Development Provide advice and assistance in business growth and development of Party B. 业务发展。对乙方的业务发展提供建议和协助。

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Regulatory Affairs Development and production of medical products and processes fall under the purview of the Food and Drug Administration (FDA) and research on these products involving animal or human studies is regulated by other laws, directives, and regulations. Project Awards under this Agreement that involve work in support of or related to FDA regulatory approval will address contingencies for Government access to regulatory rights in the event of product development abandonment or failure. Efforts conducted under this OTA shall be done ethically and in accordance with all applicable laws, directives, and regulations. The Government shall ensure performance includes regulatory expertise and guidance for candidate medical countermeasure development efforts:

  • Product Development Attach all requested documentation and attach additional pages as necessary. For all requirements include efforts of all Sublicensees. If not applicable, please so indicate by N/A.

  • Joint Development If joint development is involved, the Recipient agrees to follow the latest edition of FTA Circular 7050.1, “Federal Transit Administration Guidance on Joint Development.”

  • Business Development Company Status The Company, during a period of at least 12 months from the Closing Time, will use its commercially reasonable efforts to maintain its status as a business development company; provided, however, the Company may cease to be, or withdraw its election as, a business development company, with the approval of the board of directors and a vote of stockholders as required by Section 58 of the 1940 Act or any successor provision.

  • Status as Business Development Company The Borrower is an “investment company” that has elected to be regulated as a “business development company” within the meaning of the Investment Company Act and qualifies as a RIC.

  • Adverse Developments Promptly after the Lessee acquires knowledge thereof, written notice of:

Time is Money Join Law Insider Premium to draft better contracts faster.